Analytical Data
-
Gene name
CGb1
- Application
-
Alternative Names
CG-B1; Choriogonadotropin Subunit Beta Variant 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A6NKQ9
-
Expression Region
Tyr55~Pro153
-
Molecular Weight
14kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CGb1 recombinant protein, derived from the Chlamydia genus, has garnered significant attention in recent years due to its critical role in understanding chlamydial pathogenesis and the immune response it elicits. Chlamydia is a leading cause of sexually transmitted infections worldwide and can lead to severe reproductive health issues, including infertility. The protein CGb1, identified as a potential immunogenic target, is believed to participate in the modulation of host immune responses during infection. Research suggests that CGb1 may play a role in the bacteria's ability to evade immune detection, making it a crucial molecule for further study. By characterizing CGb1, scientists aim to elucidate its functional mechanisms and its interactions with host cells, which could pave the way for the development of novel therapeutic interventions and vaccines against chlamydial infections. Moreover, understanding its structure and function could lead to insights into the broader category of microbial pathogenesis. With the increasing incidence of chlamydial infections and the growing demand for effective prevention strategies, CGb1 recombinant protein research represents a pivotal area of investigation in microbiology and immunology, highlighting the need for innovative approaches to combat this public health challenge.
